InvestorsHub Logo
Followers 9
Posts 399
Boards Moderated 0
Alias Born 09/23/2013

Re: Steady_T post# 102995

Wednesday, 10/29/2014 8:11:38 PM

Wednesday, October 29, 2014 8:11:38 PM

Post# of 146211
Highly doubtful EbolaCide1 partial effectiveness was hydration-related only.

I don't have the protocol, but almost all animal studies ensure control animals are alike in every way possible except for the therapy to remove bias due to ancillary effects.

Therefore they almost certainly would have compared against control animals with the same fluid injection volumes and osmotic concentrations with saline or whatever other carrier fluid was used for the EbolaCide1.

USAMRIID has reputable scientists with knowledge of how to run studies and also presented their findings to their peers and superiors who also know these things. They would be embarrassed if they made such an oversight in their control animals.

So - No - this was almost certainly not a differential hydration effect due to inadequate controls.

It was a proven partial efficacy for EbolaCide1 - longer survival times but no full recoveries.

Based on the current treatments for Ebola which consists of maintaining hydration, it could just as well have been the fluid the Ebolacide was injected with that extended the life of the mice.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News